NICE rules out cannabis product on prescription in UK

The cannabis-based drug initially approved for use on the NHS in Wales should not be made available on prescription to treat muscle spasms in MS patients, according to NICE guidance.

Cannabis: NHS use of oral spray ruled out by NICE
Cannabis: NHS use of oral spray ruled out by NICE

In its updated guidance for treating MS released on Wednesday, NICE said the drug nabiximols (Sativex), an oral spray derived from the class B drug, was ‘not a cost effective treatment’ and clinicians should not offer it to patients.

The decision comes just two months after the drug was approved for use on the NHS in Wales. The NICE guidance overrules this recommendation, meaning new patients across the UK, including Wales, will not be able to receive the drug on the NHS.

The recommendation does not apply to any patients who may have already started treatment with Sativex, who should be able to continue treatment ‘until they and their NHS clinician think it appropriate to stop’, according to the guidance.

NICE recommends baclofen or gabapentin as first-line options to treat muscle spasms in MS patients, or a combination of the two treatments depending on a case-by-case basis. Tizandine and dantrolene were recommended as second-line options.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: PCNs can be at the forefront of tackling health inequlities

Viewpoint: PCNs can be at the forefront of tackling health inequlities

Dr Mark Spencer explains how the COVID-19 pandemic helped his primary care network...

GPs expected to exceed 75% flu jab uptake as NHS England reveals campaign details

GPs expected to exceed 75% flu jab uptake as NHS England reveals campaign details

The government has said it expects practices to hit a minimum 75% uptake of flu vaccination...

Red flag symptoms: Heavy menstrual bleeding

Red flag symptoms: Heavy menstrual bleeding

Possible causes of heavy menstrual bleeding (menorrhagia) include uterine and ovarian...

Details on how practices can claim COVID-19 support funding announced

Details on how practices can claim COVID-19 support funding announced

NHS England has released details on how practices can claim back additional costs...

Most GPs say scrapping revalidation and CQC checks would not affect patient safety

Most GPs say scrapping revalidation and CQC checks would not affect patient safety

Around two thirds of GPs say scrapping revalidation and CQC inspections would make...

PCNs offered funding to accelerate recruitment of social prescribers

PCNs offered funding to accelerate recruitment of social prescribers

Primary care networks (PCNs) have been offered funding in a bid to accelerate the...